Is Moderna Stock A Buy Or A Sell On The Long Road For Its Cancer Vaccine?

stock skidded in April after the company announced the full Phase 2 results of its Merck (MRK)-partnered personalized cancer vaccine. X The companies tested a combination of the vaccine — tailored to patients' individual tumor DNA — added to Merck's cancer drug Keytruda. After a year, more than…#merck #keytruda #moderna #stephanebancel #senatecommittee #pfe #fda #rsv #pfizer #gsk
Source: Reuters: Health - Category: Consumer Health News Source Type: news